Ironwood Pharmaceuticals (IRWD) Treasury Shares (2010 - 2025)

Ironwood Pharmaceuticals has disclosed Treasury Shares across 15 years of filings, most recently posting $315000.0 for Q4 2025.

• Treasury Shares for Q4 2025 came in at $315000.0, down 94.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $315000.0 (down 94.11% YoY), and the FY2025 annual result was $315000.0, down 94.11% from the prior year.
• Treasury Shares came in at $315000.0 for Q4 2025 at Ironwood Pharmaceuticals, down from $5.4 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.4 million in Q4 2024 to a low of $263260.0 in Q4 2021.
• The 5-year median for Treasury Shares is $1.2 million (2022), against an average of $2.5 million.
• Across the five-year window, Treasury Shares jumped 357.12% in 2023 and plunged 94.11% in 2025, its largest moves.
• Ironwood Pharmaceuticals' Treasury Shares stood at $263260.0 in 2021, then soared by 343.96% to $1.2 million in 2022, then surged by 357.12% to $5.3 million in 2023, then climbed by 0.16% to $5.4 million in 2024, then slumped by 94.11% to $315000.0 in 2025.
• The last three Treasury Shares figures came in at $315000.0 (Q4 2025), $5.4 million (Q4 2024), and $5.3 million (Q4 2023), per Business Quant data.